2018 ESDR Future Leaders Academy

Title: “Entrepreneurship in Dermatology”

3-5 October 2018, Budapest, Hungary

Supported by

Overview

The ESDR Academy for Future Leaders in Dermatology has been held annually since 2011 and brings together around 25 of the most promising young skin scientists with established leaders in the field for a 3-day event. Mixing scientific exchange, career advice and mentoring, the Academy provides an essential platform for young, motivated scientists to move forward in their careers. In 2018, accepted participants will also join the inuguaral ESDR Masterclass on Next-Generation Healthcare, which will take place at the conclusion of the Academy.

Objectives

The goal of this initiative is to encourage young gifted dermatologists to further pursue their academic careers through guidance and mentoring of established scientists in the field. Besides scientific sessions, there is a strong emphasis on encouraging young people to network and to exchange ideas. The Academy is an excellent opportunity for sponsoring companies to establish strong professional relationships with the next generation of leaders in dermatology.

General Information

The program is primarily open to European residents currently engaged in skin-related research (MD, PhD, Post-Doc, Resident etc). A limited number of places will be made available for participants residing outside Europe.  Participants must be 40 years old or under by 1 November 2018. Exceptions may be made for career breaks, maternity/paternity leave etc. 

Applications are reviewed on scientific merit by the ESDR Future Leaders Committee.

ESDR covers accommodation costs for all participants and travel costs for ESDR members. If you are not a member you may apply prior to the Academy. Participants must commit to staying for the entire duration of the Academy and should travel alone. All participants give oral presentations of their work and be expected to attend mentoring events. Past participants are not eligble for consideration.

PROGRAM
Wednesday 3 October 2018
 
13.30-14.00 Welcome and Self-Introductions
Menno de Rie (The Netherlands), Hervé Bachelez (France)
 
14.00-14.30 Entrepeneurship in Dermatology
Carlo Pincelli (Italy)
 
Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)
 
14.30-14.45 Epidermal barrier dysfunction and the progression of the atopic march: a new experimental model using FlgHrnr-/- mice
Andrea Braun (Germany)
 
14.45-15.00 The roles of non-coding RNAs in skin wound healing
Dongqing Li (Sweden)
 
15.00-15.15 Immunomodulatory functions of PRINS long non-coding RNA in human keratinocytes
Judit Danis (Hungary)
 
15.15-15.30 Exploring the molecular mechanisms underlying UVB responses in human keratinocytes
Serena Grossi (Switzerland)
 
15.30-15.45 Integrative characterization of ß-catenin signaling in melanoma
Pierre Sohier (France)
 
15.45-16.00 Understanding the molecular genetics of melanoma
Cristina Pellegrini (Italy) 
 
16.00-16.30 Coffee Break 
 
16.30-17.00 From Molecule to Medicine: Commercialisation of Research in Dermatology
Cath O’Neill (UK)
 
Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)
 
17.00-17.15 Personalized and precision medicine in dermatology: are we catching up?
Lynda Grine (Belgium)
 
17.15-17.30 The effect of domestic water hardness on skin barrier function and atopic eczema risk
Zarif Jabbar-Lopez (UK)
 
17.30-17.45 Exploring the role of abnormal fibroblast activity and subsequent tissue fibrosis in keloids
Jihee Kim (South Korea)
 
17.45-18.00 Role of GATA6+ cells in the upper pilo-sebaceous unit
Benedicte Oules (UK)
 
18.00-19.00 Presentation from Industry Partners 
 
Thursday 4 October 2018
 
08.30-09.00 Translational Science During Drug Discovery 
Peter Florian (Germany)
 
Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)
 
09.00-09.15 Using computers to cure cancer: bioinformatics approaches to understanding the fundamental drivers of cancer biology
Stephen Smith (UK)
 
09.15-09.30 Adaptive immunity to commensal fungi promotes skin inflammation
Saeko Nakajima (Japan)
 
09.30-09.45 Exogenous and endogenous triggers of distinct patterns of skin immunity in inflammatory skin diseases
Felix Lauffer (Germany)
 
09.45-10.00 Coloring the spots: diagnosis, measurement instruments and treatment in vitiligo
Janny Lommerts (The Netherlands)
 
10.00-10.15 Topical corticosteroids and the risk of type 2 diabetes: a pharmacoepidemiological study
Yuki Andersen (Denmark)
 
10.15-11.15 Coffee Break and Group Photo 
 
11.15-11.45 Publishing or Patenting?
Lajos Kemény (Hungary)
 
Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)
 
11.45-12.00 A compound-based therapy approach for EBS
Katrin Rietscher (Germany) 
 
12.00-12.15 Eicosanoids in atopic dermatitis an ichthyosis vulgaris
Stefan Blunder(Austria)
 
12.15-12.30 Dynamics and Heterogeneity of Hair Follicle Stem Cells
Ines Sequeira (UK)
 
12.30-12.45 A bird’s-eye view on eczema - Harmonising outcomes and datasets for atopic eczema
Louise Gerbens (The Netherlands)
 
12.45-13.15 From pharmaceutical Industry to Investment Fund, example of a professional journey
Sabine Dandiguian (France)
 
13.15-14.30 Lunch
 
14.30-15.30 Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)
 
14.30-14.45 Developing a biomarker tool for personalized biological treatment in psoriasis
Juul Van den Reek (The Netherlands)
 
14.45-15.00 Molecular investigations of psoriasis pathogenesis
Eszter Szlavicz (Hungary)
 
15.00-15.15 Topical methotrexate-goldnanoparticles are effective in dampening the innate and adaptive  immune response in an IMQ-induced psoriatic mouse model
Antonios Kolios (Switzerland)
 
15.15-15.30 Development of an iPSC-mediated strategy for skin regeneration
Patricia Peking (Austria)
 
15.30-16.00 The Universe of Genodermatoses - Is It Expanding or Shrinking
Marta Szell (Hungary) 
 
16.00-16.30 Coffee Break 
 
Friday 5 October 2018
 
08.30-09.00 Reflections on Leadership in Clinical Academia
Chris Griffiths (UK) 
 
Oral Presentations by Mentees (10 minutes plus 5 minutes discussion)
 
09.00-09.15 Evaluating the potential of targeting TGFB2 signalling to prevent metastasis of high risk subsets of early stage melanoma
Ioana Cosgarea (UK)
 
09.15-09.30 Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray automated analysis
Morteza Seyed Jafari (Switzerland)
 
09.30-09.45 Targeting skin microbiome dysbiosis to improve wound healing in epidermolysis bullosa
Christina Guttmann-Gruber (Austria)
 
09.45-11.15 Break-out Session/Coffee Break
 
11.15-11.45 Presentation of Break-out Sessions to Plenum
 
11.45-12.00 Closing Remarks and Outlook
Menno de Rie (Amsterdam), Hervé Bachelez (France)